DIETARY_SUPPLEMENT · Unmapped registry intervention
High dose IQP-LU-104 (5120mg)
Find medicine records ·
Find other trials using this name
Clinical trial
Benefit and Tolerability of IQP-LU-104 in Weight Loss
NCT03888911
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DIETARY_SUPPLEMENT · Unmapped registry intervention
Low dose IQP-LU-104 (2560mg)
Find medicine records ·
Find other trials using this name
DIETARY_SUPPLEMENT · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBenefit and Tolerability of IQP-LU-104 in Weight Loss
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Overweightunresolved
Obesityverified · MONDO: obesity disorder
Interventions
High dose IQP-LU-104 (5120mg)DIETARY_SUPPLEMENT
Low dose IQP-LU-104 (2560mg)DIETARY_SUPPLEMENT
PlaceboDIETARY_SUPPLEMENT
Sponsors & collaborators
InQpharm Grouplead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03888911 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.